New pap smear device aims to reduce pain and boost screening rates

NCT ID NCT06861504

Completed Diagnosis Sponsor: University of Michigan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called the Femscope Calm Collect Device for collecting cervical cells during cancer screening. The goal was to see if it could collect cells just as well as a traditional Pap smear but with less pain and discomfort. Thirteen healthy women aged 21-45 took part, each receiving both the new device and a standard Pap smear for comparison.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Femscope Calm Collect Device
What this could lead to: If it works, this device could make cervical cancer screening more comfortable and encourage more women to get tested regularly.
What could go wrong: This was a very small, early study with only 13 participants, so results may not apply to everyone. The device may not collect cells as well as the standard method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CERVICAL CANCER

Contacts and locations

Locations

University of Michigan Flint

Flint, Michigan, 48502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.